Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1336920/000133692022000024/ldos-20220401.htm
November 2023
October 2023
August 2023
June 2023
May 2023
May 2023
March 2023
February 2023
February 2023
February 2023
Three Months Ended | ||||||||||||||
(in millions, except margin and per share amounts) | April 1, 2022 | April 2, 2021 | ||||||||||||
Revenues | $ | 3,494 | $ | 3,315 | ||||||||||
Net income | $ | 177 | $ | 205 | ||||||||||
Net income margin | 5.1 | % | 6.2 | % | ||||||||||
Diluted earnings per share (EPS) | $ | 1.25 | $ | 1.42 | ||||||||||
Non-GAAP Measures*: | ||||||||||||||
Adjusted EBITDA | $ | 358 | $ | 389 | ||||||||||
Adjusted EBITDA margin | 10.2 | % | 11.7 | % | ||||||||||
Non-GAAP diluted EPS | $ | 1.58 | $ | 1.73 | ||||||||||
* Non-GAAP financial measures should be considered in addition to, but not as a substitute for, the information provided in accordance with GAAP. Management believes that these non-GAAP measures provide another measure of Leidos' results of operations and financial condition, including its ability to comply with financial covenants. See Non-GAAP Financial Measures at the end of this press release for more information and a reconciliation of our selected reported results to these non-GAAP measures. |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1336920/000133692022000024/ldos-20220401.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Leidos Holdings, Inc..
Leidos Holdings, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:
Rating
Learn More![]()
The increases in revenue and operating income for the three months ended April 1, 2022, as compared to the three months ended April 2, 2021, was primarily due to a net increase in volumes on higher margin programs and net profit write-ups on certain programs.
The change was primarily due to the Accelerated Share Repurchase agreement entered into by the Company on February 16, 2022, which resulted in an increase of $403 million in stock repurchases during the current quarter and $38 million in capital contributions received from our non-controlling interest in the prior year quarter, partially offset by $75 million of net proceeds from our commercial paper program in the current quarter.
Summary of Cash Flows Three Months Ended April 1,2022 April 2,2021 (in millions) Net cash provided by operating activities $ 93 $ 239 Net cash used in investing activities (21) (244) Net cash used in financing activities (519) (148) Net decrease in cash, cash equivalents and restricted cash $ (447) $ (153) Net cash provided by operating activities decreased $146 million for the three months ended April 1, 2022, when compared to the prior year quarter.
Beginning in 2022, a provision in the Tax Cuts and Jobs Act of 2017 ("TCJA") which eliminated the option to deduct research and development costs for tax purposes and requires taxpayers to capitalize and amortize the costs over five years became effective.
Stock repurchases of Leidos common stock may be made on the open market or in privately negotiated transactions with third parties including through accelerated share repurchase agreements.
On February 16, 2022, we...Read more
The increase in operating loss...Read more
Although our Credit Facilities include...Read more
We also have letters of...Read more
This was partially offset by...Read more
The increase was primarily due...Read more
Net cash used in financing...Read more
The decrease in the effective...Read more
Pursuant to these registration rights...Read more
The decrease was primarily due...Read more
The decrease in operating income...Read more
As of April 1, 2022,...Read more
The following discussion contains forward-looking...Read more
Additionally, we separately present the...Read more
Provision for Income Taxes For...Read more
We have a commercial paper...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Leidos Holdings, Inc. provided additional information to their SEC Filing as exhibits
Ticker: LDOS
CIK: 1336920
Form Type: 10-Q Quarterly Report
Accession Number: 0001336920-22-000024
Submitted to the SEC: Tue May 03 2022 12:00:40 PM EST
Accepted by the SEC: Tue May 03 2022
Period: Friday, April 1, 2022
Industry: Computer Integrated Systems Design